VENTUS THERAPEUTICS

ventus-therapeutics-logo

Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases, and cancer. Ventus' structural immunology platform offers unprecedented insight into mechanisms and molecular structures, combining core capabilities for precisely targeting the innate immune system: proprietary protein engineering capabilities that elucidate innate immune mechanisms, and leading-edge rational and structure-based drug design tools. Ventus has built an emerging pipeline of multiple drug programs addressing key targets in the innate immune system.

#SimilarOrganizations #People #Financial #Event #Website #More

VENTUS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2019-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.ventustx.com

Total Employee:
51+

Status:
Active

Contact:
514-397-9517

Email Addresses:
[email protected]

Total Funding:
370.15 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics SSL By Default


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

sionna-therapeutics-logo

Sionna Therapeutics

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

tmunity-therapeutics-logo

Tmunity Therapeutics

Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

stéphane-dorich_image

Stéphane Dorich Principal Scientist @ Ventus Therapeutics
Board_member
2020-01-01

joshua-resnick_image

Joshua Resnick Board Member @ Ventus Therapeutics
Board_member
2021-04-08

jerel-davis_image

Jerel Davis Chair of the Board of Directors @ Ventus Therapeutics
Board_member
2020-01-01

not_available_image

John Cassidy Board Member @ Ventus Therapeutics
Board_member
2022-02-01

nathaniel-brooks-horwitz_image

Nathaniel Brooks Horwitz Board Observer @ Ventus Therapeutics
Board_observer
2021-01-01

jane-pritchett-henderson_image

Jane Pritchett Henderson Member, Board of Directors, Chair of Audit Committee @ Ventus Therapeutics
Board_member
2021-11-01

Current Employees Featured

stuart-green_image

Stuart Green
Stuart Green Chief Medical Officer @ Ventus Therapeutics
Chief Medical Officer
2022-05-01

marcelo-bigal_image

Marcelo Bigal
Marcelo Bigal President and CEO @ Ventus Therapeutics
President and CEO
2019-05-01

richard-flavell_image

Richard Flavell
Richard Flavell Co-Founder @ Ventus Therapeutics
Co-Founder

christine-ha_image

Christine Ha
Christine Ha Chief Financial Officer @ Ventus Therapeutics
Chief Financial Officer
2022-03-01

hao-wu_image

Hao Wu
Hao Wu Co-Founder @ Ventus Therapeutics
Co-Founder

daniel-koerwer_image

Daniel Koerwer
Daniel Koerwer Chief Operating Officer @ Ventus Therapeutics
Chief Operating Officer
2022-07-01

thomas-tuschl_image

Thomas Tuschl
Thomas Tuschl Co-Founder @ Ventus Therapeutics
Co-Founder

g-sridhar-prasad_image

G. Sridhar Prasad
G. Sridhar Prasad Head of Protein Sciences @ Ventus Therapeutics
Head of Protein Sciences
2022-07-01

not_available_image

Jason Burch
Jason Burch Head of Chemistry @ Ventus Therapeutics
Head of Chemistry

markus-warmuth_image

Markus Warmuth
Markus Warmuth Member Board Of Directors @ Ventus Therapeutics
Member Board Of Directors
2021-09-01

Founder


hao-wu_image

Hao Wu

judy-lieberman_image

Judy Lieberman

richard-flavell_image

Richard Flavell

thomas-tuschl_image

Thomas Tuschl

Investors List

the-michael-j-fox-foundation_image

Michael J. Fox Foundation

Michael J. Fox Foundation investment in Grant - Ventus Therapeutics

novonordisk_image

Novo Nordisk

Novo Nordisk investment in Corporate Round - Ventus Therapeutics

andreessen-horowitz_image

Andreessen Horowitz

Andreessen Horowitz investment in Series C - Ventus Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series C - Ventus Therapeutics

softbank-vision-fund_image

SoftBank Vision Fund

SoftBank Vision Fund investment in Series C - Ventus Therapeutics

versant-ventures_image

Versant Ventures

Versant Ventures investment in Series C - Ventus Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Ventus Therapeutics

fonds-de-solidarit-ftq_image

Fonds de solidarité FTQ

Fonds de solidarité FTQ investment in Series C - Ventus Therapeutics

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series C - Ventus Therapeutics

biotechnology-value-fund_image

Biotechnology Value Fund

Biotechnology Value Fund investment in Series C - Ventus Therapeutics

Official Site Inspections

http://www.ventustx.com Semrush global rank: 3.14 M Semrush visits lastest month: 4.81 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ventus Therapeutics"

The Power of Resolution - Ventus Therapeutics

We are a clinical-stage biopharmaceutical company leveraging our machine learning-enabled ReSOLVEâ„¢ platform to advance a pipeline of novel medicines in immunology, inflammation, …See details»

Ventus Therapeutics Significantly Expands its Presence …

Jul 16, 2024 · The new facility serves as Ventus’ Montreal-based offices and laboratories for its drug discovery and development organization, including its medicinal chemistry, computational chemistry, DMPK, and disease biology …See details»

Overview - Ventus Therapeutics

Ventus Therapeutics is a clinical-stage biopharmaceutical company deploying leading-edge structural biology and unique machine learning and computational chemistry tools to develop a robust pipeline of novel medicines in …See details»

Ventus Therapeutics | Creating Exceptional Medicines with …

We are advancing a pipeline of novel medicines to potentially treat a wide variety of indications, including autoimmune and inflammatory diseases, dermatological diseases, and neurological …See details»

Ventus Therapeutics - LinkedIn

At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but difficult-to-drug targets. Others are building towards a future...See details»

Ventus Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Phone Number 514-397-9517 Ventus Therapeutics is a biopharmaceutical company discovering and developing novel small molecule medicines that target the innate immune system to treat …See details»

Ventus Therapeutics - LinkedIn

At Ventus, we are pioneering a unique approach to structure-based drug discovery to address biologically validated, but difficult-to-drug targets. Others are building towards a future...See details»

Overview | Ventus Therapeutics

Ventus Therapeutics deploys leading-edge structural biology and unique computational chemistry tools to discover novel small molecule medicines for challenging targets in immunology, inflammation, and neurology. Others are …See details»

Ventus Therapeutics - Overview, News & Similar companies

Apr 17, 2024 · View Ventus Therapeutics (www.ventustx.com) location in Quebec, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»

Ventus Therapeutics Company Profile 2024: Valuation, Funding ...

Developer of structural immunology-based therapeutics designed to navigate elusive targets. The company focuses on developing small-molecule medicines to target proteins in the …See details»

Overview - Ventus Therapeutics

We are looking for candidates who are capable of designing intelligent and creative solutions to complex problems, have the courage and resilience to work on elusive drug targets, and are ready to build a world-class organization from …See details»

Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in ...

Jan 3, 2024 · For more information about Ventus’ pipeline and ReSOLVE TM platform, visit www.VentusTx.com. About cGAS cGAS is an intracellular pattern recognition receptor that is …See details»

Ventus Therapeutics | Portfolio - Versant Ventures

Ventus is discovering and developing novel small molecule medicines that target the innate immune system to treat autoimmune diseases, inflammatory diseases and cancer. © 2024 …See details»

Ventus Therapeutics Opens New Facility in Waltham, MA as First …

Sep 6, 2022 · This new facility augments Ventus’ existing 10,000-square-foot facility in Montreal, which houses Ventus’ drug discovery and development organization, including its medicinal …See details»

Ventus Therapeutics Opens New Facility in Waltham, MA as First …

Sep 6, 2022 · This new facility augments Ventus’ existing 10,000-square-foot facility in Montreal, which houses Ventus’ drug discovery and development organization, including its medicinal …See details»

Ventus Therapeutics Initiates Clinical Testing of VENT-03, a First-in ...

Jan 3, 2024 · Ventus Therapeutics is a clinical-stage biopharmaceutical company deploying leading-edge structural biology and computational chemistry tools to create novel small …See details»

Ventus Therapeutics Significantly Expands its Presence in Montreal ...

Jul 16, 2024 · The new facility serves as Ventus’ Montreal-based offices and laboratories for its drug discovery and development organization, including its medicinal chemistry, computational …See details»

Pipeline | Ventus Therapeutics

Our ReSOLVEâ„¢ platform enables a highly differentiated pipeline of small molecule therapeutics for highly validated innate immunity targets. Our lead programs target the inflammasome and …See details»

Pipeline - Ventus Therapeutics

Our ReSOLVEâ„¢ platform enables a highly differentiated pipeline of small molecule therapeutics for highly validated innate immunity targets. Our lead programs target the inflammasome and …See details»

What you need to know about extreme child poverty in Armenia

1 day ago · The trap of extreme poverty, as I already said, repeats itself from generation to generation. When a child is born into extreme poverty, the family, from young to old, is already …See details»

linkstock.net © 2022. All rights reserved